Theravance Biopharma (TBPH) EBIT Growth (1y) (2014 - 2026)
Theravance Biopharma (TBPH) EBIT Growth (1y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-347.04% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
1.27% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Theravance Biopharma |
835.85 Mn |
441.18 Mn |
- |
34.30% |
| Date | Value |
|---|
| Mar 31, 2026 |
34.30% |
| Dec 31, 2025 |
317.52% |
| Sep 30, 2025 |
40.44% |
| Jun 30, 2025 |
82.65% |
| Mar 31, 2025 |
-28.79% |
| Dec 31, 2024 |
-47.44% |
| Sep 30, 2024 |
-23.71% |
| Jun 30, 2024 |
2.59% |
| Mar 31, 2024 |
55.01% |
| Dec 31, 2023 |
64.20% |
| Sep 30, 2023 |
4.20% |
| Jun 30, 2023 |
40.02% |
| Mar 31, 2023 |
35.30% |
| Dec 31, 2022 |
68.96% |
| Sep 30, 2022 |
82.95% |
| Jun 30, 2022 |
58.07% |
| Mar 31, 2022 |
54.11% |
| Dec 31, 2021 |
26.57% |
| Sep 30, 2021 |
30.02% |
| Jun 30, 2021 |
11.18% |
